| Medical Condition | Hypercortisolism in patients with diabetes/impaired glucose tolerance or hypertension |
| Facility/Clinic | Accellacare – 1917 Tradd Ct |
| Age | 18-80 |
| Gender | Male & Female |
| Description | This is a Phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, and safety of relacorilant to treat hypercortisolism in patients with cortisol-secreting adrenal adenoma or hyperplasia associated with diabetes mellitus/impaired glucose tolerance and/or uncontrolled systolic hypertension. |
| Enrollment | Open |
| Patient Commitment Duration | Up to 32 weeks |
| Number of visits in study | at least 9 |
| Patient Compensation | $60 for completed visits + $13 meal stipend for completed visits requiring the patient to be fasted |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.